Stay updated on Daratumumab Combo in MRD+ Myeloma Clinical Trial
Sign up to get notified when there's something new on the Daratumumab Combo in MRD+ Myeloma Clinical Trial page.

Latest updates to the Daratumumab Combo in MRD+ Myeloma Clinical Trial page
- Check5 days agoChange DetectedThe page no longer displays the explicit disease name and drops the related topics block, altering how the study topic and linked resources are presented on the study details page.SummaryDifference0.1%

- Check12 days agoChange DetectedA new 'Multiple myeloma' label and a 'related topics' section including MedlinePlus Genetics were added, and the site revision was updated from v3.6.2 to v3.6.3.SummaryDifference0.1%

- Check19 days agoChange DetectedThe study record now shows completed status with actual dates, replacing the previous Active, not recruiting status, and the page revision has been updated to v3.6.2. This reflects that enrollment is closed and the study timeline milestones have been updated.SummaryDifference0.2%

- Check27 days agoChange DetectedThe study details page no longer shows the disease term 'Multiple myeloma' or the related topics section (including MedlinePlus Genetics). This removes disease-specific context and related-resource links from the page.SummaryDifference0.1%

- Check34 days agoChange DetectedA recruitment status line 'No longer looking for participants' was added to indicate the study is not enrolling; new navigation/help items such as 'How to Read a Study Record', 'Common Questions', 'How to Join a Study', and related topics were introduced, along with minor formatting tweaks to the Intervention/Treatment heading and a site revision tag (v3.6.0).SummaryDifference0.3%

- Check41 days agoChange DetectedA new revision tag Revision: v3.5.5 was added. Older revision and related-topic references (Multiple myeloma, MedlinePlus Genetics, Revision: v3.5.4) were removed, indicating a backend metadata update.SummaryDifference0.1%

Stay in the know with updates to Daratumumab Combo in MRD+ Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Daratumumab Combo in MRD+ Myeloma Clinical Trial page.